Singapore - English - HSA (Health Sciences Authority)

ziwell medical (s) pte ltd - levofloxacin hemihydrate 512.46mg eqv levofloxacin - tablet, film coated - levofloxacin hemihydrate 512.46mg eqv levofloxacin 500mg

Ireland - English - HPRA (Health Products Regulatory Authority)

bluefish pharmaceuticals ab - levofloxacin - film-coated tablet - 250 milligram(s) - fluoroquinolones; levofloxacin

Malta - English - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - levofloxacin - film-coated tablet - levofloxacin 250 mg - antibacterials for systemic use

Malta - English - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - levofloxacin - film-coated tablet - levofloxacin 500 mg - antibacterials for systemic use

Australia - English - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - donepezil hydrochloride monohydrate, quantity: 10.43 mg (equivalent: donepezil hydrochloride, qty 10 ) - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch; microcrystalline cellulose; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350; lecithin - treatment of mild, moderate and severe alzheimer's disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - donepezil hydrochloride monohydrate, quantity: 5.22 mg (equivalent: donepezil hydrochloride, qty 5 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; magnesium stearate; maize starch; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350; lecithin - treatment of mild, moderate and severe alzheimer's disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - ribociclib succinate, quantity: 254.4 mg (equivalent: ribociclib, qty 200 mg) - tablet, film coated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; hyprolose; crospovidone; titanium dioxide; purified talc; xanthan gum; polyvinyl alcohol; lecithin; iron oxide black; iron oxide red - kisqali is indicated for the treatment of patients with hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative advanced or metastatic breast cancer, in combination with an aromatase inhibitor or fulvestrant, as initial endocrine-based therapy or following prior endocrine therapy.

Malta - English - Medicines Authority

sanofi s.r.l viale l. bodio, 37/b 20158, milan, italy - levofloxacin - film-coated tablet - levofloxacin 500 mg - antibacterials for systemic use

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

pharma international co., jordan - levofloxacin - film-coated tablet - 500 mg

Singapore - English - HSA (Health Sciences Authority)

novem pharma private limited - levofloxacin hemihydrate eqv to levofloxacin - tablet, film coated - levofloxacin hemihydrate eqv to levofloxacin 500 mg